Search research articles
Contact Us
Filters
Showing results (311-320 of 350) with videos related to
Page
of 35
Sort By:
Leukemia & Lymphoma
|
August 1, 1997
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma
G Pinotti, E Zucca, E Roggero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 3, 2010
Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)
A Conconi, G Martinelli, A Lopez-Guillermo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1993
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study
K S Buser, R A Joss, D Piquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1997
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)
M Fopp, M F Fey, M Bacchi, et al.
Blood
|
December 1, 1996
Lymphoma classification--the gap between biology and clinical management is closing
W Hiddemann, D L Longo, B Coiffier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2015
Histologic transformation in marginal zone lymphomas†
A Conconi, S Franceschetti, K Aprile von Hohenstaufen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1992
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma
S B Kaye, J Wanders, M Clavel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2002
Treatment of childhood Wilms' tumor without radiotherapy in Nicaragua
F Baez, F Fossati Bellani, E Ocampo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2013
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH
M Mian, A Rinaldi, A A Mensah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma
D C Betticher, A von Rohr, D Ratschiller, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 350) with videos related to
Sort By:
Page
of 35
Leukemia & Lymphoma
|
August 1, 1997
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma
G Pinotti, E Zucca, E Roggero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 3, 2010
Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)
A Conconi, G Martinelli, A Lopez-Guillermo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1993
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study
K S Buser, R A Joss, D Piquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1997
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)
M Fopp, M F Fey, M Bacchi, et al.
Blood
|
December 1, 1996
Lymphoma classification--the gap between biology and clinical management is closing
W Hiddemann, D L Longo, B Coiffier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2015
Histologic transformation in marginal zone lymphomas†
A Conconi, S Franceschetti, K Aprile von Hohenstaufen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1992
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma
S B Kaye, J Wanders, M Clavel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2002
Treatment of childhood Wilms' tumor without radiotherapy in Nicaragua
F Baez, F Fossati Bellani, E Ocampo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2013
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH
M Mian, A Rinaldi, A A Mensah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma
D C Betticher, A von Rohr, D Ratschiller, et al.
Page
of 35